The institutional trap is that healthcare buyers can now make AI look like modernization while leaving the expensive part untouched. PHTI’s warning is aimed at the spending curve, not the model market: efficiency gains have repeatedly entered American healthcare without lowering total cost healthcare keeps adding efficient technologies. BCG’s prescription turns that into an operating mandate, arguing that capacity gains come from redesigning care itself . The first failure mode is already visible: AI becomes another purchased layer inside a system built to absorb savings before patients or payers…